Bora Lim

Trials

Studies that name Bora Lim as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:13 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT07783659 · Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC

  M.D. Anderson Cancer Center · not yet recruiting · Phase IB, Zotatifin, EIF4A · principal investigator
• Ph1
  NCT07553390 · Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers

  M.D. Anderson Cancer Center · not yet recruiting · Breast Cancer · principal investigator
• Ph1
  NCT06959537 · A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC)

  M.D. Anderson Cancer Center · suspended · Breast Cancer · principal investigator
• Ph2
  NCT05554354 · Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

  National Cancer Institute (NCI) · terminated · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma · principal investigator
• Ph2
  NCT02971748 · Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

  M.D. Anderson Cancer Center · active not recruiting · Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma · principal investigator
• Ph2
  NCT02411656 · Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

  M.D. Anderson Cancer Center · active not recruiting · Edema, Erythema, Estrogen Receptor Negative · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• NRG Oncology Network Group Operations Center
  U10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026
  Named on NCT05554354